Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure


Autoria(s): Spencer, Andrew; Prince, H. Miles; Roberts, Andrew W.; Prosser, Ian W.; Bradstock, Kenneth F.; Coyle, Luke; Gill, Devinder S.; Horvath, Noemi; Reynolds, John; Kennedy, Nola
Data(s)

10/04/2009

Identificador

http://hdl.handle.net/10536/DRO/DU:30060072

Idioma(s)

eng

Publicador

American Society of Clinical Oncology

Relação

http://dro.deakin.edu.au/eserv/DU:30060072/reynolds-consolidationtherapy-2009.pdf

http://doi.org/10.1200/JCO.2008.18.8573

Palavras-Chave #thalidomide consolidation #autologous stem cell transplantation (ASCT) #multiple myeloma (MM) #progression-free survival (PFS) #overall survival (OS) #prednisone therapy
Tipo

Journal Article